Antibiotics-Induced Obesity: A Mitochondrial Perspective

Melisa J. Andrade, Chinchu Jayaprakash, Smitha Bhat, Nikolaos Evangelatos, Angela Brand, Kapaettu Satyamoorthy

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Antibiotics are the first line of treatment against infections and have contributed immensely to reduce the morbidity and mortality rates. Recently, extensive use of antibiotics has led to alterations of the gut microbiome, predisposition to various diseases and most importantly, increase in the emergence of antibiotic-resistant bacteria, which poses a major threat to global public health. Another major issue faced worldwide due to unregulated use of antibiotics in children as well as in adults is the influence of metabolism and body weight homeostasis, leading to obesity. Apart from the involvement of biosocial causes influencing diet, physical activity, and antibiotic use, pathogenesis of obesity is linked to interconnected functional alterations in cells, tissues and organs due to biochemical, epigenetic and genetic factors. Mitochondrial dysfunction is one such factor, which is becoming the primary focus of various aspects of research on multifactorial complex diseases and is providing new perspectives on etiology, biomarker-based diagnosis, and drug sensitivity. Through this review, we have made an attempt to present the interplay between use of antibiotics, obesity, and associated mitochondrial dysfunction. This may provide insights into the molecular basis, genetic predisposition and environmental triggers, which in turn may have potential clinical applications in the management of antibiotic use.

Original languageEnglish
JournalPublic Health Genomics
DOIs
Publication statusPublished - 01-04-2018

Fingerprint

Obesity
Anti-Bacterial Agents
Molecular Biology
Genetic Predisposition to Disease
Epigenomics
Homeostasis
Public Health
Biomarkers
Body Weight
Exercise
Diet
Morbidity
Bacteria
Mortality
Infection
Research
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health
  • Genetics(clinical)

Cite this

Andrade, Melisa J. ; Jayaprakash, Chinchu ; Bhat, Smitha ; Evangelatos, Nikolaos ; Brand, Angela ; Satyamoorthy, Kapaettu. / Antibiotics-Induced Obesity : A Mitochondrial Perspective. In: Public Health Genomics. 2018.
@article{273a40aad7144fac8dae95a8b74a0f4a,
title = "Antibiotics-Induced Obesity: A Mitochondrial Perspective",
abstract = "Antibiotics are the first line of treatment against infections and have contributed immensely to reduce the morbidity and mortality rates. Recently, extensive use of antibiotics has led to alterations of the gut microbiome, predisposition to various diseases and most importantly, increase in the emergence of antibiotic-resistant bacteria, which poses a major threat to global public health. Another major issue faced worldwide due to unregulated use of antibiotics in children as well as in adults is the influence of metabolism and body weight homeostasis, leading to obesity. Apart from the involvement of biosocial causes influencing diet, physical activity, and antibiotic use, pathogenesis of obesity is linked to interconnected functional alterations in cells, tissues and organs due to biochemical, epigenetic and genetic factors. Mitochondrial dysfunction is one such factor, which is becoming the primary focus of various aspects of research on multifactorial complex diseases and is providing new perspectives on etiology, biomarker-based diagnosis, and drug sensitivity. Through this review, we have made an attempt to present the interplay between use of antibiotics, obesity, and associated mitochondrial dysfunction. This may provide insights into the molecular basis, genetic predisposition and environmental triggers, which in turn may have potential clinical applications in the management of antibiotic use.",
author = "Andrade, {Melisa J.} and Chinchu Jayaprakash and Smitha Bhat and Nikolaos Evangelatos and Angela Brand and Kapaettu Satyamoorthy",
year = "2018",
month = "4",
day = "1",
doi = "10.1159/000485095",
language = "English",
journal = "Public Health Genomics",
issn = "1662-4246",
publisher = "S. Karger AG",

}

Antibiotics-Induced Obesity : A Mitochondrial Perspective. / Andrade, Melisa J.; Jayaprakash, Chinchu; Bhat, Smitha; Evangelatos, Nikolaos; Brand, Angela; Satyamoorthy, Kapaettu.

In: Public Health Genomics, 01.04.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antibiotics-Induced Obesity

T2 - A Mitochondrial Perspective

AU - Andrade, Melisa J.

AU - Jayaprakash, Chinchu

AU - Bhat, Smitha

AU - Evangelatos, Nikolaos

AU - Brand, Angela

AU - Satyamoorthy, Kapaettu

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Antibiotics are the first line of treatment against infections and have contributed immensely to reduce the morbidity and mortality rates. Recently, extensive use of antibiotics has led to alterations of the gut microbiome, predisposition to various diseases and most importantly, increase in the emergence of antibiotic-resistant bacteria, which poses a major threat to global public health. Another major issue faced worldwide due to unregulated use of antibiotics in children as well as in adults is the influence of metabolism and body weight homeostasis, leading to obesity. Apart from the involvement of biosocial causes influencing diet, physical activity, and antibiotic use, pathogenesis of obesity is linked to interconnected functional alterations in cells, tissues and organs due to biochemical, epigenetic and genetic factors. Mitochondrial dysfunction is one such factor, which is becoming the primary focus of various aspects of research on multifactorial complex diseases and is providing new perspectives on etiology, biomarker-based diagnosis, and drug sensitivity. Through this review, we have made an attempt to present the interplay between use of antibiotics, obesity, and associated mitochondrial dysfunction. This may provide insights into the molecular basis, genetic predisposition and environmental triggers, which in turn may have potential clinical applications in the management of antibiotic use.

AB - Antibiotics are the first line of treatment against infections and have contributed immensely to reduce the morbidity and mortality rates. Recently, extensive use of antibiotics has led to alterations of the gut microbiome, predisposition to various diseases and most importantly, increase in the emergence of antibiotic-resistant bacteria, which poses a major threat to global public health. Another major issue faced worldwide due to unregulated use of antibiotics in children as well as in adults is the influence of metabolism and body weight homeostasis, leading to obesity. Apart from the involvement of biosocial causes influencing diet, physical activity, and antibiotic use, pathogenesis of obesity is linked to interconnected functional alterations in cells, tissues and organs due to biochemical, epigenetic and genetic factors. Mitochondrial dysfunction is one such factor, which is becoming the primary focus of various aspects of research on multifactorial complex diseases and is providing new perspectives on etiology, biomarker-based diagnosis, and drug sensitivity. Through this review, we have made an attempt to present the interplay between use of antibiotics, obesity, and associated mitochondrial dysfunction. This may provide insights into the molecular basis, genetic predisposition and environmental triggers, which in turn may have potential clinical applications in the management of antibiotic use.

UR - http://www.scopus.com/inward/record.url?scp=85038125936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038125936&partnerID=8YFLogxK

U2 - 10.1159/000485095

DO - 10.1159/000485095

M3 - Article

AN - SCOPUS:85038125936

JO - Public Health Genomics

JF - Public Health Genomics

SN - 1662-4246

ER -